Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
egosbar
|
33K |
16M |
26 |
10/11/23 |
10/11/23 |
Charts
|
33K
|
16M
|
26
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
egosbar
|
33K |
16M |
40 |
10/11/23 |
10/11/23 |
Charts
|
33K
|
16M
|
40
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Azer-cel Hits Major Milestone in Phase 1b CAR T Trial
|
|
egosbar
|
242 |
112K |
2 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
242
|
112K
|
2
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
egosbar
|
33K |
16M |
41 |
09/11/23 |
09/11/23 |
Charts
|
33K
|
16M
|
41
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
egosbar
|
33K |
16M |
3 |
09/11/23 |
09/11/23 |
Charts
|
33K
|
16M
|
3
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
egosbar
|
33K |
16M |
9 |
09/11/23 |
09/11/23 |
Charts
|
33K
|
16M
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
egosbar
|
25K |
12M |
3 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
25K
|
12M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - MAST Study Update
|
|
egosbar
|
228 |
95K |
22 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
228
|
95K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - MAST Study Update
|
|
egosbar
|
228 |
95K |
44 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
228
|
95K
|
44
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - MAST Study Update
|
|
egosbar
|
228 |
95K |
15 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
228
|
95K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - MAST Study Update
|
|
egosbar
|
228 |
95K |
18 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
228
|
95K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
egosbar
|
25K |
12M |
16 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
25K
|
12M
|
16
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
egosbar
|
33K |
16M |
20 |
08/11/23 |
08/11/23 |
Charts
|
33K
|
16M
|
20
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
egosbar
|
33K |
16M |
3 |
08/11/23 |
08/11/23 |
Charts
|
33K
|
16M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
egosbar
|
25K |
12M |
17 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
25K
|
12M
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
egosbar
|
25K |
12M |
12 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
25K
|
12M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
egosbar
|
14K |
6.9M |
17 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
14K
|
6.9M
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
egosbar
|
25K |
12M |
22 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
25K
|
12M
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
egosbar
|
14K |
6.9M |
15 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
14K
|
6.9M
|
15
|
|
ASX - By Stock
|
CNB |
Re:
Charts & Broker Data
|
|
egosbar
|
2.0K |
743K |
2 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
2.0K
|
743K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
5 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
4 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
18 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
9 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
5 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
29 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
29
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
7 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
14 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
21 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
24 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
|
|
egosbar
|
315 |
148K |
29 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
315
|
148K
|
29
|
|
ASX - By Stock
|
IMU |
Re:
IMU Target $2.00 - Not Ramping !!!
|
|
egosbar
|
288 |
144K |
29 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
288
|
144K
|
29
|
|
ASX - By Stock
|
IMU |
Re:
IMU Target $2.00 - Not Ramping !!!
|
|
egosbar
|
288 |
144K |
52 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
288
|
144K
|
52
|
|
ASX - By Stock
|
IMU |
Re:
IMU Target $2.00 - Not Ramping !!!
|
|
egosbar
|
288 |
144K |
19 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
288
|
144K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
egosbar
|
14K |
6.9M |
55 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
14K
|
6.9M
|
55
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Greater Duchess Maiden Mineral Resource
|
|
egosbar
|
186 |
72K |
6 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
186
|
72K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
egosbar
|
14K |
6.9M |
11 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
14K
|
6.9M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
egosbar
|
25K |
12M |
13 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
25K
|
12M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
egosbar
|
25K |
12M |
8 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
25K
|
12M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
egosbar
|
25K |
12M |
8 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
25K
|
12M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
egosbar
|
85 |
29K |
11 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
85
|
29K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
egosbar
|
85 |
29K |
4 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
85
|
29K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
egosbar
|
85 |
29K |
22 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
85
|
29K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
egosbar
|
85 |
29K |
34 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
85
|
29K
|
34
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
egosbar
|
1.0K |
646K |
10 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
1.0K
|
646K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Phase 1 onCARlytics CD19 virus clinical trial opens
|
|
egosbar
|
174 |
81K |
13 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
174
|
81K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Phase 1 onCARlytics CD19 virus clinical trial opens
|
|
egosbar
|
174 |
81K |
20 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
174
|
81K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
egosbar
|
324 |
104K |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
324
|
104K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
egosbar
|
324 |
104K |
23 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
324
|
104K
|
23
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
egosbar
|
324 |
104K |
11 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
324
|
104K
|
11
|
|